bioAffinity Technologies, Inc.

BIAF · Nasdaq · SIC 8731: Services-Commercial Physical & Biological Research · Market Cap: $0.0B · 57 employees
148
SEC Filings
$1.62
Close 2026-05-21
57
Employees

Business Summary

PART I Business Overview We develop noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Our first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. CyPath Lung addresses the need for noninvasive d...

Latest Stock Quote

BIAF 2026-05-21 $1.62 O:$1.61 H:$1.69 L:$1.4 Vol:0.2M VWAP:$1.5267
origin leaf: 61a0847511f801501e5fe7e0a2fd70de615d9e9d09a9240425fe3076fdc808d6

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001493152-26-010143EDGAR74K words
2025-03-312024-12-310001641172-25-001840EDGAR—
2024-04-012023-12-310001493152-24-012358EDGAR—
2023-03-312022-12-310001493152-23-010186EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001493152-25-023405EDGAR27K words
2025-08-142025-06-300001641172-25-024163EDGAR—
2025-05-152025-03-310001641172-25-010787EDGAR—
2024-11-142024-09-300001493152-24-045954EDGAR—
2024-08-142024-06-300001493152-24-031943EDGAR—
2024-05-152024-03-310001493152-24-019615EDGAR—
2023-11-142023-09-300001493152-23-040986EDGAR—
2023-08-142023-06-300001493152-23-028453EDGAR—
2023-05-152023-03-310001493152-23-017083EDGAR—
2022-11-142022-09-300001493152-22-032248EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001493152-26-014653EDGAR1K words
2026-03-260001493152-26-012808EDGAR—
2026-03-250001493152-26-012683EDGAR—
2026-03-170001493152-26-010584EDGAR—
2026-03-130001493152-26-009986EDGAR—
2026-03-100001493152-26-009463EDGAR—
2026-03-060001493152-26-009154EDGAR—
2026-03-030001493152-26-008723EDGAR—
2026-02-250001493152-26-007965EDGAR—
2026-02-190001493152-26-007464EDGAR—

148 total filings indexed. 124 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ABSI — Absci Corp CRL — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CBIH — Cannabis Bioscience International Holdings, Inc. FOXO — FOXO TECHNOLOGIES INC. INCY — INCYTE CORP IQV — IQVIA HOLDINGS INC. NOTV — Inotiv, Inc. MXCT — MAXCYTE, INC.

Company Identity

CIK0001712762
TickerBIAF
ExchangeNasdaq
SIC8731: Services-Commercial Physical & Biological Research
IncorporatedDE
Websitehttps://www.bioaffinitytech.com
Listed2022-09-01

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e1dfe25abcd67f4b282a5bbcef5e4c72d9f912ac60fd6f90615e42d033960ced
parent: ddff1a6bf2628ab0d3435f8fd1ef13d8c3517d882fc83b675331efcdaa8c705b
content hash: fc64bfb4b4de9cea97fd3c5c32014388924bf2a5b9ce53f3eb38fc0d9d9f8536
signed: 2026-06-02T19:00:24.878Z
sources: 15 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf